Review
Open access
Sep 2026
Biomimetic Nanocarriers for Glioblastoma Therapy: Translational Advances and Strategic Challenges
Glioblastoma (GBM) is the most aggressive and common type of brain tumor, characterized by rapid growth and infiltration, as well as high resistance to conventional treatments. Given the persistent challenge posed by the bloodbrain barrier (BBB) to effective drug delivery, a shift in therapeutic strategies is required....
Bhawana Jain, Sunita Sanwaria, A. Hadap et al.
· Cancers · 0 citations